共 50 条
Management of pituitary incidentaloma
被引:18
|作者:
Boguszewski, Cesar Luiz
[1
]
de Castro Musolino, Nina Rosa
[2
]
Kasuki, Leandro
[3
]
机构:
[1] Univ Fed Parana, Univ Hosp, Dept Internal Med, Endocrine Div SEMPR, Ave Agostinho Leao Jr 285, BR-80030110 Curitiba, Parana, Brazil
[2] Univ Sao Paulo, Clin Hosp, Psychiat Inst, Funct Neurosurg Div,Med Sch, Sao Paulo, SP, Brazil
[3] Univ Fed Rio de Janeiro, Endocrinol Div, Med Sch, Neuroendocrinol Res Ctr, Rio De Janeiro, Brazil
关键词:
incidentaloma;
pituitary gland;
apoplexy;
NATURAL-HISTORY;
FOLLOW-UP;
DIFFERENTIAL-DIAGNOSIS;
ADENOMAS;
PREVALENCE;
HORMONE;
HYPERCORTISOLISM;
MICROADENOMAS;
CABERGOLINE;
LESIONS;
D O I:
10.1016/j.beem.2019.04.002
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Pituitary incidentalomas (PIs) represent a modern clinical entity increasingly recognized due to advances and easier accessibility to imaging techniques. By definition, PIs should be detected during brain imaging performed for investigation of a non-pituitary disease. Although anatomic variations, technical artefacts or pituitary hyperplasia might also be interpreted as PIs, the most relevant incidentally detected lesions are those that fulfill radiological criteria for a pituitary adenoma in asymptomatic patients or in the presence of subclinical diseases. The natural history of PIs is not fully determined, but there is a wealth of evidence indicating that most microincidentalomas (lesions < 10 mm) have a benign course, whereas macroincidentalomas (>= 10 mm) deserve more attention due to an increased risk for hormone abnormalities and mass effects. This concept is important to keep in mind for an optimal diagnostic and therapeutic management of PIs that avoids harmful iatrogenesis and unnecessary health care costs. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数:10
相关论文